|
|
H2014/CTD1625/386
|
JANUMET 50/1000
|
SITAGLIPTIN PHOSPHATE AND METFORMIN PHOSPHATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2014/CTD1624/385
|
JANUMET 50/850
|
SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2014/CTD816/747
|
JANUVIA 100 MG TABLETS
|
SITAGLIPTIN PHOSPHATE
|
IMPERIAL MANAGED SOLUTIONS EAST AFRICA LTD- MLOLONGO
|
Registered
|
Details →
|
|
|
H2014/CTD814/748
|
JANUVIA 25MG TABLETS
|
SITAGLIPTIN PHOSPHATE
|
IMPERIAL MANAGED SOLUTIONS EAST AFRICA LTD- MLOLONGO
|
Registered
|
Details →
|
|
|
H2014/CTD815/749
|
JANUVIA 50MG TABLETS
|
SITAGLIPTIN PHOSPHATE
|
IMPERIAL MANAGED SOLUTIONS EAST AFRICA LTD- MLOLONGO
|
Registered
|
Details →
|
|
|
CTD9030
|
JARDIAN 10 TABLET
|
EMPAGLIFLOZIN INN
|
MADAWA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD9031
|
JARDIAN 25 TABLET
|
EMPAGLIFLOZIN INN
|
MADAWA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7286/14083
|
JARDIANCE 10 MG TABLETS
|
EMPAGLIFLOZIN
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7291/14170/R1
|
JARDIANCE 25 MG TABLETS
|
EMPAGLIFLOZIN
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10147/22718
|
JARDIMET 5/500 TABLET
|
EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE
|
MADAWA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9658/22135
|
JARDY-MET 12.5/1000 TABLET
|
EMPAGLIFLOZIN & METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD9657/22114
|
JARDY-MET 12.5/500 TABLET
|
EMPAGLIFLOZIN & METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD9656/22108
|
JARDY-MET 5/500 TABLET
|
EMPAGLIFLOZIN & METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
14726
|
JASOCAINE INJECTION-2%
|
LIDOCAINE HYDROCHLORIDE USP
|
MADAWA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2008/18334/150
|
JASOQUIN INJECTION
|
QUININE DIHYDROCHLORIDE
|
MADAWA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2016/CTD2056/169
|
JEKOF SYRUP
|
AMBROXOL HCL,SALBUTAMOL SULPHATE
|
NATIONAL PHARMACY LTD
|
Registered
|
Details →
|
|
|
H2016/CTD2056/169/R1
|
JEKOF SYRUP
|
AMBROXOL HCL,SALBUTAMOL SULPHATE
|
National Pharmacy Ltd
|
Retained
|
Details →
|
|
|
H2001/0089
|
JENMOX 500MG
|
AMOXICILLIN TRIHYDRATE
|
MEDICREST PLUS LIMITED.
|
Registered
|
Details →
|
|
|
H2013/CTD1294/345
|
JENTADUETO 2,5 MG/850 MG TABLETS
|
LINAGLIPTIN & METFORMIN HCL
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2021/CTD7248/14292
|
JENTIN MET TABLETS 50/1000MG
|
SITAGLIPTIN / METFORMIN
|
UNISEL LTD
|
Registered
|
Details →
|